Koo, Bo Kyung

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

Koo, B. K., Kim, D., Joo, S. K., Kim, J. H., Chang, M. S., Kim, B. G., Lee, K. L., & Kim, W. (2017) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentNutrition and Health in Aging

Cited by 440

Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.

Shin, A., Koo, B. K., Lee, J. Y., & Kang, E. H. (2024) · BMJ

Diabetes Treatment and ManagementDementia and Cognitive Impairment Research

Cited by 69

The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks

Kim, E. K., Kwak, S. H., Jung, H. S., Koo, B. K., Moon, M. K., Lim, S., Jang, H. C., Park, K. S., & Cho, Y. M. (2019) · Diabetes Care

Mobile Health and mHealth ApplicationsDiabetes Management and Education

Cited by 61

Difference between old and young adults in contribution of β‐cell function and sarcopenia in developing diabetes mellitus

Koo, B. K., Roh, E., Yang, Y. S., & Moon, M. K. (2016) · Journal of Diabetes Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsNutrition and Health in Aging

Cited by 48

Correction: Prevalence of Gestational Diabetes Mellitus in Korea: A National Health Insurance Database Study

Koo, B. K., Lee, J. H., Kim, J., Jang, E. J., & Lee, C.-H. (2016) · PLOS ONE

Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 5

Liver Stiffness Directs Intrahepatic Cholesterol Accumulation Through YAP/TAZ in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Lee, N. Y., Choi, M. G., Ryu, H. J., Min, Y. J., Kim, S. M., Chung, Y., Koo, B. K., Kang, Y. P., Kim, W., & Koo, J. H. (2026) · Advanced Science

Liver Disease Diagnosis and TreatmentHippo pathway signaling and YAP/TAZ

Cited by 2